Abdominal Fat Is Directly Associated With Inflammation In Persons With Type-2 Diabetes Regardless Of Glycemic Control - A Jordanian Study

被引:10
|
作者
Bawadi, Hiba [1 ]
Katkhouda, Rami [2 ]
Tayyem, Reema [3 ]
Kerkadi, Abdelhamid [1 ]
Raad, Samira Bou [4 ]
Subih, Hadil [2 ]
机构
[1] Qatar Univ, Coll Hlth Sci, Human Nutr Dept, QU Hlth, Bldg 106,Univ St,POB 2713, Doha, Qatar
[2] Jordan Univ Sci & Technol, Dept Nutr & Food Technol, Irbid, Jordan
[3] Univ Jordan, Dept Clin Nutr & Dietet, Amman, Jordan
[4] Amer Univ Sci & Technol, Dept Nutr & Food Sci, Beirut, Lebanon
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2019年 / 12卷
关键词
BMI; C-reactive protein; diabetes; IL-6; inflammation; obesity; C-REACTIVE PROTEIN; OXIDATIVE STRESS; BODY-FAT; INSULIN-RESISTANCE; TNF-ALPHA; MASS; ADIPOSITY; MELLITUS; OBESITY; HYPERGLYCEMIA;
D O I
10.2147/DMSO.S214426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: Systemic inflammation is related to the progression of complications associated with diabetes. This study aimed to investigate the association between general and abdominal obesity and inflammation in patients with type-2 diabetes with or without glycemic control. Methods: A total of 198 men (n=73) and women (n=125) diagnosed with type 2 diabetes participated in this study. General obesity markers, body mass index (BMI), and abdominal fat were assessed. Circulating concentrations of glycated hemoglobin (HbA1C), C-reactive protein (CRP), and serum interleukin-6 (IL-6) were determined. Poor glycemic control and good glycemic control were defined as having fasting HbA1C concentrations >= 7% and <7%, respectively. Multivariate adjusted analysis of covariance was used to determine the relation between BMI and abdominal fat and markers of inflammation in patients with good and poor glycemic control. Results: Patients in <7% HbA1C category, those with high abdominal fat had approximate to 262% higher CRP and approximate to 30.6% higher IL-6 compared to those with low abdominal fat (p<0.05). Patients in >= 7% HbA1C category, those with high abdominal fat had approximate to 41.4% higher CRP and approximate to 33.9% higher IL-6 compared to those with low abdominal fat (p<0.05). Abdominal fat was directly related to CRP (p<0.023) and IL-6 (p<0.002) concentrations in both groups of type-2 diabetic patients with <7% and >= 7% HbA1C. In patients with >= 7% HbA1C, BMI was directly related to CRP (p<0.02) and IL-6 (p<0.047). Whereas in patients with <7% HbA1C, BMI was not associated with CRP or IL-6 concentrations. Conclusion: High level of abdominal fat is associated with systemic inflammation in type-2 diabetes regardless of glycemic control. Abdominal fat is a better predictor (determinant) of inflammation than BMI in patients with type-2 diabetes with or without glycemic control.
引用
收藏
页码:2411 / 2417
页数:7
相关论文
共 50 条
  • [31] Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes
    Sam, Susan
    Haffner, Steven
    Davidson, Michael H.
    D'Agostino, Ralph B., Sr.
    Feinstein, Steven
    Kondos, George
    Perez, Alfonso
    Mazzone, Theodore
    DIABETES CARE, 2009, 32 (05) : 932 - 937
  • [32] Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
    Bain, Stephen C.
    Hansen, Brian Bekker
    Hunt, Barnaby
    Chubb, Barrie
    Valentine, William J.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (01) : 98 - 105
  • [33] VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes A cohort study
    Zhang, Qin
    Fang, Wen
    Ma, Li
    Wang, Zhao-Di
    Yang, Yun-Mei
    Lu, Yuan-Qiang
    MEDICINE, 2018, 97 (15)
  • [34] A retrospective database study of the demographic features and glycemic control of patients with type 2 diabetes in Kinshasa, Democratic Republic of the Congo
    Sagastume, Diana
    Mertens, Elly
    Sibongwere, Deogratias Katsuva
    Dimbelolo, Jean-Claude
    Kabundi, Jean Clovis Kalobu
    de Man, Jeroen
    Van Olmen, Josefien
    Penalvo, Jose L.
    BMC MEDICINE, 2022, 20 (01)
  • [35] Mobile Diabetes Intervention for Glycemic Control in 45-to 64-Year-Old Persons With Type 2 Diabetes
    Quinn, Charlene C.
    Shardell, Michelle D.
    Terrin, Michael L.
    Barr, Erik A.
    Park, DoHwan
    Shaikh, Faraz
    Guralnik, Jack M.
    Gruber-Baldini, Ann L.
    JOURNAL OF APPLIED GERONTOLOGY, 2016, 35 (02) : 227 - 243
  • [36] Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes
    Hartemann-Heurtier, Agnes
    Halbron, Marine
    Golmard, Jean-Louis
    Jacqueminet, Sophie
    Bastard, Jean-Philippe
    Rouault, Christine
    Ayed, Amine
    Pieroni, Laurence
    Clement, Karine
    Grimaldi, Andre
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (01) : 37 - 43
  • [37] Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control
    Seinfeld, Janice
    Sobrevilla, Alfredo
    Rosales, Maria Laura
    Ibanez, Mauricio
    Ruiz, Delia
    Penny, Eduardo
    Londono, Sergio
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (05) : 661 - 669
  • [38] Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study
    Zamani, Batool
    Tabatabizadeh, Seyyed Mashaalah
    Gilasi, Hamidreza
    Yazdani, Shadi
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2024, 44 (04) : 385 - 391
  • [39] Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study
    Li, Jung-Chi
    Cheng, Po-Chung
    Huang, Chien-Nin
    Jian, Li-Fen
    Wu, Ying-Syuan
    Lin, Chih-Li
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [40] Late-night-dinners is associated with poor glycemic control in people with type 2 diabetes: The KAMOGAWA-DM cohort study
    Sakai, Ryosuke
    Hashimoto, Yoshitaka
    Ushigome, Emi
    Miki, Akane
    Okamura, Takuro
    Matsugasumi, Masako
    Fukuda, Takuya
    Majima, Saori
    Matsumoto, Shinobu
    Senmaru, Takafumi
    Hamaguchi, Masahide
    Tanaka, Muhei
    Asano, Mai
    Yamazaki, Masahiro
    Oda, Yohei
    Fukui, Michiaki
    ENDOCRINE JOURNAL, 2018, 65 (04) : 395 - 402